ABOUT THIS EPISODE
Novo Nordisk and Eli Lilly found the popular medicines reduce molecular markers of age.
This story was written by Antonio Regalado and narrated by Noa - newsoveraudio.com.
Listen to more curated articles on the Noa app.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of MIT Technology Review Narrated.
OTHER EPISODES IN THIS PODCAST
Quantifying our lives is easier than it’s ever been. But a philosopher of games warns that external metrics and data can never capture what’s truly important.
This story was written by Bryan Gardiner and narrated by Noa - newsoveraudio.com. Listen to more of the world's best journalism on the No…
As payouts from the AI boom soar, a job at SK Hynix can put you at the front of the matchmakers’ queue.
This story was written by Michelle Kim and narrated by Noa - newsoveraudio.com
The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.
This story was written by Jessica Hamzelou and narrated by Noa - newsoveraudio.com. Listen to more of the world's best journalism on the Noa app.
This summer has been a scorcher for much of the Northern Hemisphere. June and July marked the hottest two-month stretch in Europe since record-keeping began. The heat isn’t over yet, but some scientists are already looking ahead to 2027, which could break records again for a combi…
The company has drawn governments, a major chipmaker, and the Pentagon into an effort to control fragile photons and build a useful quantum machine. It aims to be the first.
This story was written by James O'Donnell and narrated by Noa - newsoveraudio.com
Disclaimer: The podcast and artwork embedded on this page are from MIT Technology Review, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
